These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 27581786)
1. Drug-resistant CXCR4-positive cells have the molecular characteristics of EMT in NSCLC. Yin H; Wang Y; Chen W; Zhong S; Liu Z; Zhao J Gene; 2016 Dec; 594(1):23-29. PubMed ID: 27581786 [TBL] [Abstract][Full Text] [Related]
2. MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells. Kitamura K; Seike M; Okano T; Matsuda K; Miyanaga A; Mizutani H; Noro R; Minegishi Y; Kubota K; Gemma A Mol Cancer Ther; 2014 Feb; 13(2):444-53. PubMed ID: 24258346 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway. Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256 [TBL] [Abstract][Full Text] [Related]
4. Interaction of hnRNP K with MAP 1B-LC1 promotes TGF-β1-mediated epithelial to mesenchymal transition in lung cancer cells. Li L; Yan S; Zhang H; Zhang M; Huang G; Chen M BMC Cancer; 2019 Sep; 19(1):894. PubMed ID: 31492158 [TBL] [Abstract][Full Text] [Related]
5. Implication of epithelial-mesenchymal transition in IGF1R-induced resistance to EGFR-TKIs in advanced non-small cell lung cancer. Zhou J; Wang J; Zeng Y; Zhang X; Hu Q; Zheng J; Chen B; Xie B; Zhang WM Oncotarget; 2015 Dec; 6(42):44332-45. PubMed ID: 26554308 [TBL] [Abstract][Full Text] [Related]
6. Gefitinib promotes CXCR4-dependent epithelial to mesenchymal transition via TGF-β1 signaling pathway in lung cancer cells harboring EGFR mutation. Zhu Q; Zhang Z; Lu C; Xu F; Mao W; Zhang K; Shou H; Liu Z; Gu J; Ge D Clin Transl Oncol; 2020 Aug; 22(8):1355-1363. PubMed ID: 31900845 [TBL] [Abstract][Full Text] [Related]
7. PLEK2 mediates metastasis and vascular invasion via the ubiquitin-dependent degradation of SHIP2 in non-small cell lung cancer. Wu DM; Deng SH; Zhou J; Han R; Liu T; Zhang T; Li J; Chen JP; Xu Y Int J Cancer; 2020 May; 146(9):2563-2575. PubMed ID: 31498891 [TBL] [Abstract][Full Text] [Related]
8. CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer. Tu Z; Xie S; Xiong M; Liu Y; Yang X; Tembo KM; Huang J; Hu W; Huang X; Pan S; Liu P; Altaf E; Kang G; Xiong J; Zhang Q Int J Oncol; 2017 Feb; 50(2):505-514. PubMed ID: 28000861 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells. Jung MJ; Rho JK; Kim YM; Jung JE; Jin YB; Ko YG; Lee JS; Lee SJ; Lee JC; Park MJ Oncogene; 2013 Jan; 32(2):209-21. PubMed ID: 22370645 [TBL] [Abstract][Full Text] [Related]
10. Effects of FOXJ2 on TGF-β1-induced epithelial-mesenchymal transition through Notch signaling pathway in non-small lung cancer. Yang Q; Cao X; Tao G; Zhou F; Zhao P; Shen Y; Chen X Cell Biol Int; 2017 Jan; 41(1):79-83. PubMed ID: 27611107 [TBL] [Abstract][Full Text] [Related]
11. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis. Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760 [TBL] [Abstract][Full Text] [Related]
12. Pirfenidone plays a biphasic role in inhibition of epithelial-mesenchymal transition in non-small cell lung cancer. Fujiwara A; Shintani Y; Funaki S; Kawamura T; Kimura T; Minami M; Okumura M Lung Cancer; 2017 Apr; 106():8-16. PubMed ID: 28285699 [TBL] [Abstract][Full Text] [Related]
13. Downregulation of SATB2 is critical for induction of epithelial-to-mesenchymal transition and invasion of NSCLC cells. Kucuksayan H; Ozes ON; Akca H Lung Cancer; 2016 Aug; 98():122-129. PubMed ID: 27393518 [TBL] [Abstract][Full Text] [Related]
14. CD44 silencing decreases the expression of stem cell-related factors induced by transforming growth factor β1 and tumor necrosis factor α in lung cancer: Preliminary findings. Nurwidya F; Takahashi F; Kato M; Baskoro H; Hidayat M; Wirawan A; Takahashi K Bosn J Basic Med Sci; 2017 Aug; 17(3):228-234. PubMed ID: 28446126 [TBL] [Abstract][Full Text] [Related]
15. miR-16 mimics inhibit TGF-β1-induced epithelial-to-mesenchymal transition via activation of autophagy in non-small cell lung carcinoma cells. Wang H; Zhang Y; Wu Q; Wang YB; Wang W Oncol Rep; 2018 Jan; 39(1):247-254. PubMed ID: 29138833 [TBL] [Abstract][Full Text] [Related]
16. Interaction between non-small-cell lung cancer cells and fibroblasts via enhancement of TGF-β signaling by IL-6. Abulaiti A; Shintani Y; Funaki S; Nakagiri T; Inoue M; Sawabata N; Minami M; Okumura M Lung Cancer; 2013 Nov; 82(2):204-13. PubMed ID: 24011634 [TBL] [Abstract][Full Text] [Related]
17. RCCD1 depletion attenuates TGF-β-induced EMT and cell migration by stabilizing cytoskeletal microtubules in NSCLC cells. Wu J; He Z; Yang XM; Li KL; Wang DL; Sun FL Cancer Lett; 2017 Aug; 400():18-29. PubMed ID: 28455245 [TBL] [Abstract][Full Text] [Related]
18. Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer. Wang L; Yang H; Lei Z; Zhao J; Chen Y; Chen P; Li C; Zeng Y; Liu Z; Liu X; Zhang HT Oncogene; 2016 Feb; 35(7):867-77. PubMed ID: 25961934 [TBL] [Abstract][Full Text] [Related]
19. Decitabine reverses TGF-β1-induced epithelial-mesenchymal transition in non-small-cell lung cancer by regulating miR-200/ZEB axis. Zhang N; Liu Y; Wang Y; Zhao M; Tu L; Luo F Drug Des Devel Ther; 2017; 11():969-983. PubMed ID: 28405157 [TBL] [Abstract][Full Text] [Related]
20. miR‑181b‑5p mediates TGF‑β1-induced epithelial-to-mesenchymal transition in non-small cell lung cancer stem-like cells derived from lung adenocarcinoma A549 cells. Li X; Han J; Zhu H; Peng L; Chen Z Int J Oncol; 2017 Jul; 51(1):158-168. PubMed ID: 28534939 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]